Corneal Neovascularization and Hypoxia from Contact Lenses
What corneal neovascularization and hypoxia are
Corneal neovascularization, or CNV, is the growth of new blood vessels into the cornea. The cornea is the clear dome at the front of the eye. A healthy cornea has no blood vessels. It stays clear because light passes through it to reach the retina. When new vessels grow into the cornea, they can cloud the tissue and blur vision. Contact lens wear is the most common cause of this problem in otherwise healthy eyes.
The cornea has no blood supply, so it does not get oxygen through vessels. Most of its oxygen comes from the air, dissolved in the tear film. A contact lens sits between the air and the cornea. A lens that does not let enough oxygen through starves the cornea of air. This low-oxygen state is called hypoxia. Hypoxia stresses the cornea and can drive a series of changes over time.
When corneal cells run low on oxygen, they release a protein called VEGF. VEGF stands for vascular endothelial growth factor. It tells the body to grow new blood vessels. In a healthy eye, signals that promote vessels stay in balance with signals that block them. Hypoxia tips that balance. New vessels then creep in from the limbus, the rim of tissue that surrounds the cornea.
Contact lens wear is the leading cause of non-inflammatory corneal neovascularization. Low-oxygen hydrogel lenses and overnight wear carry the highest risk. About 41 million people in the United States wear contacts. Even a small share who develop hypoxic changes adds up to a large number of cases each year. Many early cases go unnoticed because mild vessel growth causes no symptoms.
Long-term contact lens wear can also damage the limbal stem cells. These cells live in the limbus and keep the corneal surface healthy. When they are hurt by hypoxia, the corneal surface becomes unstable. This is called contact lens-induced limbal stem cell deficiency. It can happen along with neovascularization or on its own. Patients may notice lens intolerance, redness, and blurred vision that does not go away with lens refit.
Risk factors and causes linked to contact lenses
A lens is rated by how much oxygen passes through it. This rating is called Dk/t. Low-Dk/t hydrogel lenses allow less oxygen to reach the cornea. Silicone-hydrogel lenses are made with a material that allows much more oxygen through. A controlled study found that wearers of low-oxygen lenses showed an increase of about 0.5 points on a 0 to 4 vessel grading scale after 9 months of extended wear. Wearers of high-Dk silicone-hydrogel lenses showed no measurable change.
Sleeping in lenses closes off airflow to the cornea. The eyelid already lowers oxygen at night, even without a lens. Add a lens, and the cornea can spend hours in a low-oxygen state. Extended-wear schedules raise the risk of neovascularization far above daily-wear schedules. This holds true even when the lens is FDA-approved for overnight wear, though newer silicone-hydrogel overnight lenses carry less risk than older hydrogel models.
A tight-fitting lens traps debris and reduces tear flow under the lens. That effect worsens hypoxia. Long duration of lens wear in years is also a risk factor, because small amounts of hypoxic stress add up. Patients who have worn lenses for 10 years or more need careful limbal checks at each visit, even when vision feels stable.
A few other factors raise the risk of hypoxic corneal changes.
- Poor lens hygiene that leaves deposits on the lens surface.
- Pre-existing dry eye or ocular surface disease.
- Smoking, which lowers tear film oxygen levels.
- High altitude or airline cabin air, which dries the tear film.
- Not following the prescribed lens replacement schedule.
Symptoms and how eye doctors detect this problem
Early corneal neovascularization usually causes no symptoms. Vessels start at the limbus and grow slowly toward the central cornea. Small amounts of peripheral vessel growth, up to 1 to 2 millimeters from the limbus, are sometimes called a normal response to lens wear. Deeper or more central vessels are the sign that matters. That is why regular eye exams are so important for long-time lens wearers.
As the condition moves forward, patients may notice several signs. Redness at the limbus is common. Lens intolerance, meaning that the lenses feel uncomfortable after short wear times, is another clue. Blurred vision, glare, and light sensitivity can follow. In advanced cases, a white or yellow waxy area called lipid keratopathy can appear in the cornea. Scarring at this stage can cause lasting vision loss.
Diagnosis is made during a slit-lamp exam. The slit lamp is a microscope with a bright, thin beam of light. Your eye doctor uses it to view the cornea in great detail. The exam grades vessel depth, which can be superficial or deep in the stroma. It also measures how far the vessels extend toward the central cornea. Photographs taken at visits track changes over time.
Grading helps decide treatment. Mild peripheral vessels in a lens wearer may only need a lens change. Deep stromal vessels, signs of edema, or early lipid keratopathy call for closer follow-up and sometimes medication. Very advanced disease with central scarring may need surgery. Your eye doctor will explain the grade and discuss what it means for your lens wear.
A few signs tell the clinician the problem is getting worse.
- New vessels that reach closer to the pupil than at the last visit.
- Corneal cloudiness or swelling on exam.
- New lipid deposits near a vessel.
- A drop in vision that does not improve with a clean lens or a new prescription.
- Limbal redness that becomes chronic and does not settle overnight.
Treatment options and recent developments
First-line treatment is to stop wearing the offending lens, or to switch to a lens with higher oxygen permeability. High-Dk silicone-hydrogel lenses allow much more oxygen through and often let early vessels regress. Regressed vessels may appear as empty outlines, called ghost vessels, with no active blood flow. Ghost vessels can refill if hypoxia returns, so a careful lens plan matters even after things settle.
When vessels do not regress with lens changes, medical options may help. Topical corticosteroid drops can control related inflammation and slow vessel growth. Off-label anti-VEGF drugs such as bevacizumab and ranibizumab have been used as eye drops or as small injections under the conjunctiva. Short-term studies show these treatments can shrink vessel diameter. These drugs are FDA-approved for retinal diseases, not for corneal neovascularization, so treatment decisions are made case by case with your eye doctor.
Severe cases with visually important scarring or lipid keratopathy may need a procedure.
- Fine-needle diathermy uses a small probe to close larger feeder vessels.
- Argon-laser photocoagulation uses laser energy to seal feeder vessels.
- Lamellar or penetrating keratoplasty, a corneal transplant, is reserved for end-stage disease with dense scarring.
Research since 2023 has focused on sustained-release anti-VEGF delivery for the cornea. Nanoparticle carriers and slow-release implants are being studied in animals and early human trials. None are FDA-approved for this condition yet. If you are offered an experimental therapy, ask whether it is part of a registered clinical trial and what the expected follow-up looks like.
Dry eye and surface inflammation make hypoxia worse. Treatment often includes artificial tears, warm compresses for the eyelids, and prescription drops for chronic dry eye. A break from lens wear for several weeks, paired with dry eye therapy, gives the cornea a chance to recover before you return to lenses.
Prognosis, prevention, and when to see a doctor
Most patients with early corneal neovascularization do well once they stop low-oxygen lens wear. Superficial vessels often regress within weeks to months of a lens refit. Deeper stromal vessels take longer and may not regress fully. Ghost vessels are a sign of prior damage that is no longer active. They are also a warning that careful lens care must continue for life.
Outlook depends on how far the condition progressed before treatment. Mild peripheral neovascularization usually does not cause lasting vision loss. Moderate cases with stromal vessels may cause mild glare or blur even after vessels regress. Severe disease with lipid keratopathy or scarring in the central cornea can leave lasting vision changes. Early detection and a timely lens change are the most important steps in preserving vision.
Most cases of contact lens-induced neovascularization can be prevented. A careful routine lowers the risk to very low levels.
- Wear high-Dk silicone-hydrogel lenses unless your eye doctor advises otherwise.
- Avoid overnight wear unless your lens is specifically prescribed for that schedule.
- Follow the manufacturer replacement schedule for your lenses, every day, two weeks, or month as directed.
- Replace your lens case every 3 months and air-dry it face-down between uses.
- Come in for a contact lens check every 12 months, and sooner if lenses feel uncomfortable.
Book a same-week visit if you notice any of these changes. Redness at the edge of the cornea that does not go away overnight. Lenses that feel fine in the morning but painful by evening. Blurry vision that does not improve with a fresh lens or drops. Glare, halos, or a hazy patch in your vision. Any eye pain that appears during lens wear deserves same-day care, because pain is a warning sign for infection as well as severe hypoxia.
A short list of topics helps you get the most from a lens visit. Bring up each point with your eye doctor.
- Whether the current lens material is the best oxygen option for your schedule.
- Any signs of early vessel growth at the limbus at this visit.
- The option to switch to daily disposables or move away from overnight wear.
- Warning signs that should prompt a visit before the next yearly exam.
- Whether photographs on file would help track the cornea over time.
Common Questions About Corneal Neovascularization and Contact Lenses
Active vessels often shrink once hypoxia is fixed, but they rarely disappear fully. After a lens refit or a lens break, vessels may become ghost vessels with no active flow. These outlines can stay for years. The fix is not pretty, but it does protect vision in most early cases. Advanced vessels with scarring usually do not go back to normal, which is why early detection matters so much.
A switch to a high-Dk silicone-hydrogel lens is often the single most helpful step. The change raises oxygen delivery to the cornea and allows early vessels to regress. It does not reverse scarring or lipid deposits. Your eye doctor will check that the new fit is correct, because a tight lens can still cause hypoxia even with a high-Dk material.
Most early cases do not cause pain. Some patients feel mild lens intolerance, a gritty feeling, or tiredness in the eyes by evening. Pain usually points to something else, such as infection or a corneal abrasion. Any new eye pain during lens wear should lead to lens removal and a same-day call to your eye doctor.
Yes. Early vessel growth shows up on a slit-lamp exam long before patients notice visual change. A yearly contact lens check is the main way to catch these changes. Patients who wear lenses many hours a day or who have worn lenses for many years may benefit from shorter visit intervals. Photography at the slit lamp helps compare the cornea across visits.
Vessels in the peripheral cornea often do not change daytime vision. Night driving can be harder if vessels reach closer to the central cornea or if scarring or swelling develops. Glare from oncoming headlights and halos around streetlights are common complaints. Your eye doctor can measure how the condition affects your vision and suggest ways to reduce night-driving symptoms.
Most patients see vessel shrinkage within 4 to 12 weeks of a refit to a high-Dk lens or a lens break. Full regression can take several months. A follow-up visit about 6 weeks after the change is typical. Your eye doctor may take photos at that visit to compare with baseline images.
Active or recent corneal neovascularization can change the planning for eye surgery. Large vessels may bleed during procedures. Scarring can affect measurements used to set lens implant power. Tell your surgeon about any history of neovascularization before LASIK, PRK, or cataract surgery. A preoperative evaluation will decide whether treatment is needed first.
Schedule a contact lens check today
A short lens exam is the best way to catch early hypoxic changes before they affect your vision. Call our office to book a contact lens check, review your lens material and schedule, and get personal advice on protecting your cornea for the long run.